[FG] Gärtner Jan

Vetter Marcus (2024) ‘https://onco-hema.healthbooktimes.org/article/125802-personalized-organoid-based-treatments-in-older-patients-with-cancer-a-registry-study-in-progress’, healthbook TIMES Oncology Hematology [Preprint], (21). Available at: https://doi.org/10.36000/hbt.oh.2024.21.160.

Chiru, E.D. et al. (2024) ‘SIOG2024-1-P-012 Emergence of APIS BREAST CANCER SUBTYPING KIT as a viable RNA-based risk-stratification tool in older BC patients. Results from a Swiss Cohort’, in SIOG. Montreal: Elsevier BV (SIOG), p. 101863. Available at: https://doi.org/10.1016/j.jgo.2024.101863.

Chiru, E.D. et al. (2024) ‘SIOG2024-1-P-022 Routine serum biomarkers as risk stratification parameters for older pancreatic cancer patients. Reports from a single center swiss cohort study’, in SIOG. Montreal: Elsevier BV (SIOG), p. 101872. Available at: https://doi.org/10.1016/j.jgo.2024.101872.

Javier-González, M. et al. (2024) ‘SIOG2024-3-P-059 Mortalityand cause of death in people older than 85 years of age with gastrointestinal cancer: a single-site experience’, in SIOG. Montreal: Elsevier BV (SIOG), p. 101922. Available at: https://doi.org/10.1016/j.jgo.2024.101922.

Petitat-Berli, M. et al. (2024) ‘SIOG2024-1-P-023 Precision Oncology in elderly cancer patients: a single-center experience’, in SIOG. Montreal: Elsevier BV (SIOG), p. 101873. Available at: https://doi.org/10.1016/j.jgo.2024.101873.

Zhao, Y. et al. (2024) ‘SIOG2024-1-OA-007 Unlocking the potential of liquid biopsy applications in personalized care for older adults with cancer: Statement from SIOG (International Society of Geriatric Oncology) Translational Working Group’, in SIOG. Montreal: Elsevier BV (SIOG), p. 101851. Available at: https://doi.org/10.1016/j.jgo.2024.101851.

Marcus Vetter (2024) ‘Third Swiss Annual Meeting on HER2-Positive Breast Cancer: Recent Advances and New Challenges’, healthbook TIMES Oncology Hematology [Preprint], (21). Available at: https://doi.org/10.36000/hbt.oh.2024.21.152.

Sivan Schipper, Jan Gärtner and Christopher Boehlke (2024) ‘Psychedelika-assistierte Therapie bei Total Pain am Lebensende: Eine therapeutische Perspektive für die Zukunft?’, palliative.ch, 22(3), pp. 1–80. Available at: https://doi.org/10.1024/1660-6426/a000009.

Schipper, S. et al. (2024) ‘Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases’, Cochrane Database of Systematic Reviews, 2024(9). Available at: https://doi.org/10.1002/14651858.cd015383.pub2.

Boehlke, C. et al. (2024) ‘Pharmacological interventions for pruritus in adult palliative care patients’, Cochrane Database of Systematic Reviews, 2024(8). Available at: https://doi.org/10.1002/14651858.CD008320.pub4.

Seibel, Katharina et al. (2024) ‘Implementation of a digital distress detection system in palliative care: qualitative data on perspectives of a multiprofessional palliative care team’, BMC Palliative Care, 23(1). Available at: https://doi.org/10.1186/s12904-024-01530-3.

Marcus Vetter (2024) ‘Evolving Treatment Landscape in Endometrial Cancer’, healthbook TIMES Oncology Hematology [Preprint], (20). Available at: https://doi.org/10.36000/hbt.oh.2024.20.149.

Gaertner, Jan et al. (2024) ‘Pharmacological treatment of cancer pain and opioid induced nausea and vomiting: online survey and comparison with current guidelines’, Supportive Care in Cancer, 32(7). Available at: https://doi.org/10.1007/s00520-024-08628-7.

Marcus Vetter (2024) ‘Antibody-Drug Conjugates in Cancer’, healthbook TIMES Oncology Hematology [Preprint], (20). Available at: https://doi.org/10.36000/hbt.oh.2024.20.145.

Chiru, Elena D et al. (2024) ‘Abstract PO1-14-02: Real world application of a 21-gene recurrence score in a Swiss single center breast cancer population. A comparative analysis of treatment administration before and after TAILORx’, in SABCS. San Antonio: American Association for Cancer Research (AACR) (SABCS), pp. PO1–14–02–PO1–14–02. Available at: https://doi.org/10.1158/1538-7445.sabcs23-po1-14-02.

Vetter, Marcus et al. (2024) ‘Abstract PO4-03-01: Enhancing Breast Cancer Subtyping: APIS Breast Cancer Subtyping Kit Proliferative Signature’s Potential for Improved Proliferation Assessment and Recurrence Prediction’, in SABCS. San Antonio: American Association for Cancer Research (AACR) (SABCS), pp. PO4–03–01–PO4–03–01. Available at: https://doi.org/10.1158/1538-7445.sabcs23-po4-03-01.

Vetter, Marcus et al. (2024) ‘Abstract PS15-08: Final Overall Survival (OS) analysis of the SAKK 21/12 trial. CR1447 in HR+/HER2- metastatic breast cancer and androgen receptor positive triple negative breast cancer’, in SABCS. San Antonio USA: American Association for Cancer Research (AACR) (SABCS), pp. PS15–08–PS15–08. Available at: https://doi.org/10.1158/1538-7445.sabcs23-ps15-08.

Vetter, Marcus et al. (2024) ‘Abstract PO5-18-04: Effect of Digoxin on clusters of circulating tumor cells in patients with metastatic breast cancer (DICCT)’, in SABCS. San Antonio: American Association for Cancer Research (AACR) (SABCS), pp. PO5–18–04–PO5–18–04. Available at: https://doi.org/10.1158/1538-7445.sabcs23-po5-18-04.

Müller, E. et al. (2024) ‘Screening for Palliative Care Need in Oncology: Validation of Patient-Reported Outcome Measures’, Journal of Pain and Symptom Management, 67(4), pp. 279–289.e6. Available at: https://doi.org/10.1016/j.jpainsymman.2023.12.013.

Vetter Marcus (2024) ‘Recent Developments in Treatment of Older Patients with Breast Cancer’, healthbook TIMES Oncology Hematology [Preprint], (19). Available at: https://doi.org/10.36000/hbt.oh.2024.19.142.

Vetter Marcus (2024) ‘Caring for the Professional Caregivers in Cancer Medicine: An Overlooked Necessity’, healthbook TIMES Oncology Hematology [Preprint], (19). Available at: https://doi.org/10.36000/hbt.oh.2024.19.134.

Zwimpfer, T.A. et al. (2024) Management of Patients with Hypersensitivity to Platinum Salts and Taxane in Gynecological Cancers: A Cross-Sectional Study by the European Network of Young Gynaecologic Oncologists (ENYGO). MDPI AG. Available at: https://doi.org/10.20944/preprints202402.1168.v1.

Cathomas, Marionna et al. (2024) ‘Adherence to enhanced recovery after surgery (ERAS) in older adults following colorectal resection’, Journal of Geriatric Oncology. 12.09.2024, 15(8). Available at: https://doi.org/10.1016/j.jgo.2024.102062.

Chiru, Elena Diana et al. (2024) ‘Application of a 21-Gene Recurrence Score in a Swiss Single-Center Breast Cancer Population: A Comparative Analysis of Treatment Administration before and after TAILORx’, Diagnostics, 14. Available at: https://doi.org/10.3390/diagnostics14010097.

Gärtner, Jan et al. (2024) ‘SOP – Admission criteria for the palliative ward’, Onkologie, 30, pp. 67–69. Available at: https://doi.org/10.1007/s00761-022-01170-3.

Jan Gärtner et al. (2024) ‘Inconsistencies in the pharmacological management of common symptoms in palliative care: A physician survey’, in 13th World Research Congress of the European Association for Palliative Care. Barcelona (13th World Research Congress of the European Association for Palliative Care). Available at: https://doi.org/10.1177/02692163241242338.

Rudolf, Fiona et al. (2024) ‘Pulmonary Tumor Thrombotic Microangiopathy in a Patient with Rapid Progressive Triple-Negative Breast Cancer’, Case Reports in Oncology, 17, pp. 277–282. Available at: https://doi.org/10.1159/000535873.

Weber, S. et al. (2024) ‘Grundlagen der Schmerztherapie und Symptomlinderung’. Stuttgart: Georg Thieme Verlag KG. Available at: https://doi.org/10.1055/f-0002-0002-b000000789.

Sivan Schipper et al. (2024) ‘Psychedelic-assisted therapy for treatment of anxiety, depression and existential distress in life-threatening disease’, in 13th World Research Congress of the European Association for Palliative Care. Barcelona (13th World Research Congress of the European Association for Palliative Care). Available at: https://doi.org/10.1177/02692163241242338.

Ullrich, Fabian et al. (2024) ‘Impact of immunological aging on T cell-mediated therapies in older adults with multiple myeloma and lymphoma’, Journal for immunotherapy of cancer, 12. Available at: https://doi.org/10.1136/jitc-2024-009462.

Vetter Marcus (2023) ‘Geriatric Assessment of Older Patients with Cancer: Recent Data and Updated Recommendations’, healthbook TIMES Oncology Hematology [Preprint], (18). Available at: https://doi.org/10.36000/hbt.oh.2023.18.131.

Vetter Marcus (2023) ‘Advancing Ovarian Cancer Treatment: The Latest Insights on PARP Inhibitors from ASCO 2023’, healthbook TIMES Oncology Hematology [Preprint], (18). Available at: https://doi.org/10.36000/hbt.oh.2023.18.128.

Vetter Marcus (2023) ‘Boosting Immunity and Enhancing Wellbeing: The Transformative Impact of Supportive Care on Cancer Outcomes’, healthbook TIMES Oncology Hematology [Preprint], (18). Available at: https://doi.org/10.36000/hbt.oh.2023.18.125.

Müller, E. et al. (2023) ‘Interrater agreement of multi-professional case review as reference standard for specialist palliative care need: a mixed-methods study’, BMC Palliative Care, 22(1). Available at: https://doi.org/10.1186/s12904-023-01281-7.

Smaling HJA et al. (2023) ‘Interventions that may increase control at the end of life in persons with dementia: the cross-cultural CONT-END acceptability study protocol and pilot-testing’, BMC Palliative Care, 22(1), p. 142. Available at: https://doi.org/10.1186/s12904-023-01249-7.

Chiru, E.D. et al. (2023) Application of a 21-Gene Recurrence Score in a Swiss Single Center Breast Cancer Population. A Comparative Analysis of Treatment Administration before and after TAILORx. MDPI AG. Available at: https://doi.org/10.20944/preprints202311.0395.v1.

Chiru E.D. et al. (2023) ‘Clinical application of the 21-gene oncotype recurrence score in an older cohort: A single center experience’, Translational Oncology, 36. Available at: https://doi.org/10.1016/j.tranon.2023.101724.

Chiru, E.D. et al. (2023) ‘2306P How TAILORx changed treatment allocation based on 21-gene recurrence score in the daily clinic: A single center retrospective analysis’, in ESMO. Madrid: Elsevier BV (ESMO), p. S1179. Available at: https://doi.org/10.1016/j.annonc.2023.09.1333.

Landin, Julia, Weber, Walter Paul and Vetter, Marcus (2023) ‘New treatment options in system therapy for breast carcinoma and associated new side effects’, Therapeutische Umschau. Revue therapeutique, 80(8), pp. 353–358.

Vetter, M.H.F. et al. (2023) ‘220P Biomarker of blood age and inflammation in older cancer patients might predict outcome’, in ESMO. Madrid: Elsevier BV (ESMO), p. S269. Available at: https://doi.org/10.1016/j.annonc.2023.09.2943.

Wallrabenstein, Till et al. (2023) ‘Upfront Taxane Could Be Superior to Pegylated Liposomal Doxorubicin (PLD): A Retrospective Real-World Analysis of Treatment Sequence Taxane–PLD versus PLD–Taxane in Patients with Metastatic Breast Cancer’, Cancers, 15(20). Available at: https://doi.org/10.3390/cancers15204953.

Allemann-Su, Yu-Yin et al. (2023) ‘Distinct Cognitive Function Profiles Are Associated With a Higher Presurgery Symptom Burden in Patients With Breast Cancer’, Cancer Nursing, 46(4), pp. E208–E217. Available at: https://doi.org/10.1097/NCC.0000000000001114.

Gaertner J et al. (2023) ‘Effect of opioids for breathlessness in heart failure: A systematic review and meta-analysis’, Heart, 109(14), pp. 1064–1071. Available at: https://doi.org/10.1136/heartjnl-2022-322074.

Vetter Marcus (2023) ‘Artificial Intelligence in Cancer Medicine: The Future of Cancer Care?’, healthbook TIMES Oncology Hematology [Preprint], (16). Available at: https://doi.org/10.36000/hbt.oh.2023.16.105.

Grasic Kuhar, Cvetka et al. (2023) ‘Changes in the quality of life of early breast cancer patients and comparison with the normative Slovenian population’, Radiology and Oncology, 57(2), pp. 211–219. Available at: https://doi.org/10.2478/raon-2023-0019.

Vetter, Marcus et al. (2023) ‘Digital voice analysis as a measure of frailty and distress: A feasibility study (DIVAN).’, in ASCO. Chicago: American Society of Clinical Oncology (ASCO) (ASCO), pp. TPS12139–TPS12139. Available at: https://doi.org/10.1200/jco.2023.41.16_suppl.tps12139.

Wallrabenstein T et al. (2023) ‘Pegylated liposomal doxorubicin (PLD) in daily practice—A single center experience of treatment with PLD in patients with comorbidities and older patients with metastatic breast cancer’, Cancer Medicine, 12(12), pp. 13388–13396. Available at: https://doi.org/10.1002/cam4.6041.

Gaertner J, Zimmermann F. and Simone CB 2nd (2023) ‘The value of patient reported outcomes in palliative radiotherapy: A discussion in light of current findings’, Annals of Palliative Medicine, 12(3), pp. 611–615. Available at: https://doi.org/10.21037/apm-23-147.

Trittler, R. et al. (2023) ‘3PC-014 Metamorphine instead of polysubstance use?’, Section 3: Production and compounding [Preprint]. Available at: https://doi.org/10.1136/ejhpharm-2023-eahp.37.

Batzler, Yann-Nicolas, Gärtner, Jan and Neukirchen, Martin (2023) ‘Current therapeutic strategies in the treatment of pain, dyspnoea, and nausea’, MMW-Fortschritte der Medizin, 165, pp. 51–57. Available at: https://doi.org/10.1007/s15006-023-3104-8.

Biskup, Ewelina et al. (2023) ‘Pertuzumab as second- or later-line therapy for human epidermal growth factor receptor 2-positive metastatic breast cancer: A clinical experience’, Molecular and Clinical Oncology, 19(1). Available at: https://doi.org/10.3892/mco.2023.2648.

Chiru, Elena-Diana and Vetter, Marcus (2023) ‘Benefits and Applications of Oncotype DX Breast Recurrence Score Testing among Breast Cancer Patients: Current Recommendations and Controversies’, Healthbook TIMES Oncology Hematology, 16, pp. 20–27. Available at: https://doi.org/10.36000/hbt.oh.2023.16.107.

Dettwiler, Dimitri et al. (2023) ‘Clinical and pathological factors and outcome of central nervous system metastasis in breast cancer’, Frontiers in Oncology, 13. Available at: https://doi.org/10.3389/fonc.2023.1247402.

Dondi, Arthur et al. (2023) ‘Detection of isoforms and genomic alterations by high-throughput full-length single-cell RNA sequencing in ovarian cancer’, Nature Communications, 14. Available at: https://doi.org/10.1038/s41467-023-43387-9.

Felix Müller et al. (2023) ‘Lysergic acid diethylamide for depression — a randomized, double-blind, low dose-controlled phase ii trial’, in 36th ECNP Congress. Barcelona (36th ECNP Congress). Available at: https://doi.org/10.1016/j.nsa.2023.103912.

Julia Landin, Walter Paul Weber, Marcus Vetter (2023) New treatment options in systemic therapy for breast cancer and associated new side effects. Aerzteverlag medinfo AG.

Leo, Cornelia et al. (2023) ‘Routine Genetic Testing of Germline Breast Cancer Susceptibility - Challenges and Opportunities’, Healthbook TIMES Oncology Hematology, 17. Available at: https://doi.org/10.36000/HBT.OH.2023.17.117.

Vetter, Marcus et al. (2023) ‘Integrating Geriatric Care in Clinical Oncology Practice: Recommendations from an Interdisciplinary Professional Survey Study in a Single-Cancer Center in Switzerland’, Healthbook TIMES Oncology Hematology, 16(2), pp. 14–19. Available at: https://doi.org/10.36000/hbT.OH.2023.16.106.

Vetter, Marcus and Heinzelmann, Viola (2023) ‘Comprehensive Review on PARP Inhibitors in Ovarian Cancer: A Breakthrough in Diagnostic and Therapeutic Approaches’, Healthbook TIMES Oncology Hematology, 17. Available at: https://doi.org/10.36000/hbt.oh.2023.17.120.

Vetter Marcus Heizelmann Viola (2023) ‘Comprehensive Review on PARP Inhibitors in Ovarian Cancer: A Breakthrough in Diagnostic and Therapeutic Approaches’, Healthbook times [Preprint].

Jentschke E. et al. (2023) ‘Acute confusional states and delirium in palliative care’, Onkologie, 29, pp. 141–146. Available at: https://doi.org/10.1007/s00761-022-01281-x.

Bausewein, C. et al. (2022) ‘National strategy for palliative care of severely ill and dying people and their relatives in pandemics (PallPan) in Germany - study protocol of a mixed-methods project’, BMC Palliative Care, 21(1). Available at: https://doi.org/10.1186/s12904-021-00898-w.

McLaughlin PMJ et al. (2022) ‘Maintenance Therapy with Aromatase Inhibitor in epithelial Ovarian Cancer (MATAO): study protocol of a randomized double-blinded placebo-controlled multi-center phase III Trial’, BMC Cancer, 22(1), p. 508. Available at: https://doi.org/10.1186/s12885-022-09555-8.

Restivo G et al. (2022) ‘Live slow-frozen human tumor tissues viable for 2D, 3D, ex vivo cultures and single-cell RNAseq’, Communications Biology, 5(1), p. 1144. Available at: https://doi.org/10.1038/s42003-022-04025-0.

Schipper, S. et al. (2022) ‘Psychedelic/entactogen-assisted therapy for treatment of anxiety, depression and existential distress in adult palliative care’, Cochrane Database of Systematic Reviews, 2022(11). Available at: https://doi.org/10.1002/14651858.CD015383.

Vetter, Marcus et al. (2022) ‘Hormone Receptor Expression in Primary and Recurrent High-Grade Serous Ovarian Cancer and Its Implications in Early Maintenance Treatment’, International Journal of Molecular Sciences, 23(22). Available at: https://doi.org/10.3390/ijms232214242.

Vetter, Marcus et al. (2022) ‘Hormone Receptor Expression in Primary and Recurrent High-Grade Serous Ovarian Cancer and Its Implications in Early Maintenance Treatment’, International Journal of Molecular Sciences, 23(22), p. 14242. Available at: https://doi.org/10.3390/ijms232214242.

Hamelin, B. et al. (2022) Single-cell analysis reveals inter- and intratumour heterogeneity in metastatic breast cancer. Cold Spring Harbor Laboratory. Available at: https://doi.org/10.1101/2022.10.16.512415.

Gärtner J et al. (2022) ‘Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: Results from ASCLEPIOS I and II’, Multiple Sclerosis Journal, 28(10), pp. 1562–1575. Available at: https://doi.org/10.1177/13524585221078825.

Müller, E. et al. (2022) ‘Development of a screening tool for the need of specialist palliative care in oncologic inpatients: Study protocol for the ScreeningPALL Study’, BMJ Open, 12(9), p. e059598. Available at: https://doi.org/10.1136/bmjopen-2021-059598.

He L et al. (2022) ‘Efficacy and Safety of Apatinib for Radiation-induced Brain Injury Among Patients With Head and Neck Cancer: An Open-Label, Single-Arm, Phase 2 Study’, International Journal of Radiation Oncology Biology Physics, 113(4), pp. 796–804. Available at: https://doi.org/10.1016/j.ijrobp.2022.03.027.

Diamantopoulou Z et al. (2022) ‘The metastatic spread of breast cancer accelerates during sleep’, Nature, 607(7917), pp. 156–162. Available at: https://doi.org/10.1038/s41586-022-04875-y.

Pfohl U et al. (2022) ‘A RAS-Independent Biomarker Panel to Reliably Predict Response to MEK Inhibition in Colorectal Cancer’, Cancers, 14(13). Available at: https://doi.org/10.3390/cancers14133252.

Tenge T et al. (2022) ‘Inpatient Specialist Palliative Care in Patients With Left Ventricular Assist Devices (LVAD): A Retrospective Case Series’, Frontiers in Cardiovascular Medicine, 9, p. 879378. Available at: https://doi.org/10.3389/fcvm.2022.879378.

Bischof E et al. (2022) ‘Adherence to bone health guidelines in patients with hormone receptor-positive early breast cancer: Status and clinical impact in a Swiss cohort experience’, Bone Reports, 16, p. 101160. Available at: https://doi.org/10.1016/j.bonr.2021.101160.

Ehrbar V. et al. (2022) ‘Managing Cancer as a Family Disease - Feasibility, Satisfaction and Family Functioning after Short-Time Counselling for Families with Parental Cancer’, Family Journal, 30(2), pp. 200–208. Available at: https://doi.org/10.1177/10664807211052484.

Gaertner J and Fusi-Schmidhauser T (2022) ‘Dexmedetomidine: a magic bullet on its way into palliative care— a narrative review and practice recommendations’, Annals of Palliative Medicine, 11(4), pp. 1491–1504. Available at: https://doi.org/10.21037/apm-21-1989.

Scheidmann MC et al. (2022) ‘An In Vivo CRISPR Screen Identifies Stepwise Genetic Dependencies of Metastatic Progression’, Cancer Research, 82(4), pp. 681–694. Available at: https://doi.org/10.1158/0008-5472.CAN-21-3908.

Seibel, K. et al. (2022) ‘Implementation of an acute palliative care unit for COVID-19 patients in a tertiary hospital: Qualitative data on clinician perspectives’, Palliative Medicine, 36(2), pp. 332–341. Available at: https://doi.org/10.1177/02692163211059690.

Allemann-Su, Yu-Yin et al. (2022) ‘Pre-Surgery Demographic, Clinical, and Symptom Characteristics Associated with Different Self-Reported Cognitive Processes in Patients with Breast Cancer’, Cancers. 05.07.2022, 14(13), p. 3281. Available at: https://doi.org/10.3390/cancers14133281.

Böhlke, C et al. (2022) ‘Pharmakologische Interventionen gegen Pruritus (Juckreiz) bei Palliativpatienten’, in Deutsche Gesellschaft für Palliativmedizin. Bremen (Deutsche Gesellschaft für Palliativmedizin).

Müller, EA et al. (2022) ‘Sensitivität und Spezifität der Integrated Palliative Care Outcome Scale als Screening auf Bedarf an spezialisierter Palliativversorgung bei onkologischen Patient*innen: preliminary results’, in Deutsche Gesellschaft für Palliativmedizin. Bremen (Deutsche Gesellschaft für Palliativmedizin). Available at: https://doi.org/10.1055/s-0042-1754023.

Müller, MJ et al. (2022) ‘Multiprofessionelle Fallbesprechungen als Referenzkriterium zur Ermittlung des Bedarfs an spezialisierter palliativmedizinischer Versorgung: Beurteiler-Übereinstimmung und Argumentationslinien’, in Deutsche Gesellschaft für Palliativmedizin. Bremen (Deutsche Gesellschaft für Palliativmedizin). Available at: https://doi.org/10.1055/s-0042-1754035.

Oseledchyk A. et al. (2022) ‘2021 Update On Systemic Therapy for Breast Cancer’. The HealthBook Company Ltd, pp. 122–129. Available at: https://doi.org/10.36000/hbt.oh.2022.11.070.

Gartner J. et al. (2022) ‘Erratum zu: SOP – Aufnahmekriterien auf die Palliativstation (Die Onkologie, (2022), 10.1007/s00761-022-01170-3)’, Onkologie [Preprint]. Available at: https://doi.org/10.1007/s00761-022-01225-5.

Hornemann B. et al. (2022) ‘SOP—Anxiety’, Onkologie, 28, pp. 1015–1021. Available at: https://doi.org/10.1007/s00761-022-01238-0.

Schwartz J. et al. (2022) ‘Depression in palliative care’, Onkologie, 28, pp. 931–936. Available at: https://doi.org/10.1007/s00761-022-01182-z.

Zernikow, B et al. (2022) ‘Notfälle in der Symptomkontrolle’, in Zernikow, B. (ed.) Pädiatrische Palliativmedizin. Heidelberg: Springer (Pädiatrische Palliativmedizin), p. 321ff.

Kotsis, F. et al. (2021) ‘Ift88, but not Kif3a, is required for establishment of the periciliary membrane compartment’, Biochemical and Biophysical Research Communications, 584, pp. 19–25. Available at: https://doi.org/10.1016/j.bbrc.2021.10.075.

Correia AL et al. (2021) ‘Author Correction: Hepatic stellate cells suppress NK cell-sustained breast cancer dormancy.’, 600(7887). Available at: https://doi.org/10.1038/s41586-021-04104-y.

Sobottka, Bettina et al. (2021) ‘Establishing standardized immune phenotyping of metastatic melanoma by digital pathology’, Laboratory Investigation, 101(12), pp. 1561–1570. Available at: https://doi.org/10.1038/s41374-021-00653-y.

Andreas, M. et al. (2021) ‘Interventions for palliative symptom control in COVID-19 patients’, Cochrane Database of Systematic Reviews, 2021(8). Available at: https://doi.org/10.1002/14651858.CD015061.

Mueller, E. et al. (2021) ‘Lessons learned from introducing last aid courses at a university hospital in Germany’, Healthcare (Switzerland), 9(7), p. 906. Available at: https://doi.org/10.3390/healthcare9070906.

Irmisch, Anja et al. (2021) ‘The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision support’, Cancer Cell, 39(3), pp. 288–293. Available at: https://doi.org/10.1016/j.ccell.2021.01.004.

Mayer EL et al. (2021) ‘Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study’, The Lancet Oncology, 22(2), pp. 212–222. Available at: https://doi.org/10.1016/S1470-2045(20)30642-2.

Bischof E., Hurni B. and Vetter M. (2021) ‘Management of Elderly and Old Cancer Patients − Geriatric Oncology’, Healthbook TIMES Oncology Hematology, 10(4), pp. 28–33. Available at: https://doi.org/10.36000/hbt.oh.2021.10.061.

Correia, Ana Luísa et al. (2021) ‘Hepatic stellate cells suppress NK cell-sustained breast cancer dormancy’, Nature, 594(7864), pp. 566–571. Available at: https://doi.org/10.1038/s41586-021-03614-z.

Seibel, K. et al. (2021) ‘The Ad Hoc Establishment of an Acute Palliative Care (PC) Ward for Covid-19 Patients in a Tertiary University Hospital in Germany – The Perspective of the Staff and Stakeholders Involved’, in EAPC World Congress. Berlin (EAPC World Congress).

Vetter M. and Ebner S. (2021) ‘ESMO Congress 2021 News: Update Systemic Therapy in Early and Advanced Breast Cancer’, Healthbook TIMES Oncology Hematology, 9(3), pp. 88–91. Available at: https://doi.org/10.36000/hbT.OH.2021.09.052.

Vetter M. and Leary A. (2021) ‘Targeted Therapy in Ovarian Cancer’, Healthbook TIMES Oncology Hematology, 8(2), pp. 50–58. Available at: https://doi.org/10.36000/hbt.oh.2021.08.033.